Cases 1 - 4 of 4
Nunnally v. Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv16442
Plaintiff:
Lawrence Nunnally
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Shatzman v. Boehringer Ingelheim Corp. et al
as 3:2023cv10424
Plaintiff:
Karyn Shatzman
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RXC Acquisition Company v. Alkermes, Inc. et al
as 8:2021cv02264
Defendant:
WESLEY CHAPEL RX LLC, CANAL STREET PHARMACY LLC, Brooksville Drugs Inc. and others
Cross Defendant:
NEW CARE PHARMACY LLC, MEDICAL CENTER PHARMACY LLC, TAMPA SPECIALTY PHARMACY LLC and others
Plaintiff:
RXC ACQUISITION COMPANY doing business as RXCROSSROADS BY MCKESSON and RXC Acquisition Company a Delaware corporation doing business as RXCrossroads by Mckesson
Not Classified By Court:
Jonathan C. Koch
Cause Of Action: 28 U.S.C. § 1332 Diversity-(Citizenship)
De Luca v. Sanofi-Aventis U.S. LLC et al
as 9:2020cv80179
Defendant:
Chattem Inc., GlaxoSmithKline LLC, Pfizer Inc and others
Plaintiff:
Patrick A De Luca
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
